Communiqués LifeVantage Corporation

Actions

LFVN

US53222K2050

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 26/08/2026			Varia. 5j.	Varia. 1 janv.
6,610 ^USD	-3,36%		+1,69%	+7,31%

21/08	Lifevantage Corporation approuve le versement d'un dividende trimestriel en numéraire, payable le 15 septembre 2026	CI
07/05	Transcript : LifeVantage Corporation, Q3 2026 Earnings Call, May 06, 2026

Communiqués

24/08	LifeVantage Declares Quarterly Dividend	AQ
21/08	LifeVantage Declares Quarterly Dividend	AQ
13/08	LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026	AQ
11/08	LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
11/08	LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer	AQ
06/05	Lifevantage: Fiscal Q3 Earnings Snapshot	AQ
06/05	LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026	AQ
06/05	LifeVantage Declares Quarterly Dividend	AQ
22/04	LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026	AQ
21/04	LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack	AQ
20/04	LifeVantage Inspires with ‘Breakthrough’ Announcements at 2026 Momentum Academy in Las Vegas	AQ
16/04	LifeVantage Appointing Terrence Moorehead as Chief Executive Officer	AQ
09/04	LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026	AQ
02/04	LifeVantage Announces Expansion of its European Footprint with Market Opening in Portugal	AQ
16/03	LifeVantage to Participate in the Sidoti Small Cap Conference	AQ
04/02	Lifevantage: Fiscal Q2 Earnings Snapshot	AQ
04/02	LifeVantage Declares Quarterly Dividend	AQ
04/02	LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan	AQ
04/02	LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026	AQ
21/01	LifeVantage to Announce Second Quarter Fiscal Year 2026 Results on February 4, 2026	AQ
12/01	LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showcasing Innovation and Integration	AQ
07/01	LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation	AQ
06/01	LifeVantage to Participate in the 28th Annual ICR Conference	AQ
10/12	LifeVantage to Participate in Water Tower Fireside Chat on Thursday, December 11, 2025	AQ
12/11	New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health	AQ